Research Article
Clinical Relationship between Steatocholecystitis and Gallbladder Contractility Measured by Cholescintigraphy
Table 5
Univariable analysis for clinical risk factors of steatocholecystitis in patients with calculous cholecystitis.
| Variable | Steatocholecystitis (, 16.1%) | Nonsteatocholecystitis (, 83.9%) | value |
| Age (years, mean ± SD) | 46.2 ± 12.6 | 55.4 ± 16.1 | <0.001 | Men/women (%) | 13 (25.5)/38 (74.5) | 133 (50.2)/132 (49.8) | 0.001 | DM (%) | 5 (9.8) | 32 (12.1) | 0.81 | HTN (%) | 9 (17.6) | 90 (34) | 0.02 | BMI (kg/m2, mean ± SD) | 25.9 ± 4.1 | 24.9 ± 3.6 | 0.05 | Hb (g/dL, mean ± SD) | 13.3 ± 1.6 | 13.6 ± 1.9 | 0.24 | Platelet (103/mm3, mean ± SD) | 275.8 ± 84.3 | 257.5 ± 76.6 | 0.13 | AST (IU/L, mean ± SD) | 25.8 ± 12.5 | 31 ± 28.9 | 0.21 | ALT (IU/L, mean ± SD) | 40.4 ± 34.4 | 34.5 ± 40.2 | 0.32 | Total bilirubin (mg/dL, mean ± SD) | 0.7 ± 0.4 | 1.2 ± 3.9 | 0.42 | Total cholesterol (mg/dL, mean ± SD) | 169.9 ± 35 | 167.5 ± 39.7 | 0.69 | TG (mg/dL, mean ± SD) (median/IQR) | 102.5 ± 69.7 88/56.5–125 | 112.3 ± 70.2 95.5/64.8–139 | 0.43 0.34 | LDL (mg/dL, mean ± SD) | 102.7 ± 26.9 | 98.2 ± 32.5 | 0.43 | HDL (mg/dL, mean ± SD) | 51.4 ± 16.4 | 50.9 ± 14.9 | 0.84 | GBEF (%, mean ± SD) | 57.6 ± 39.7 | 39.3 ± 41.9 | 0.004 |
|
|
SD: standard deviation; : number; DM: diabetes mellitus; HTN: hypertension; GB: gallbladder; BMI: body mass index; Hb: hemoglobin; AST: aspartate aminotransferase; ALT: alanine aminotransferase; TG: triglyceride; IQR: interquartile range; LDL: low-density lipoprotein; HDL: high-density lipoprotein; GBEF: gallbladder ejection fraction.
|